BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11476735)

  • 1. The renal urodilatin system: clinical implications.
    Forssmann W; Meyer M; Forssmann K
    Cardiovasc Res; 2001 Aug; 51(3):450-62. PubMed ID: 11476735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The renal paracrine peptide system--possible urologic implications of urodilatin.
    Meyer M; Stief CG; Becker AJ; Truss MC; Taher A; Jonas U; Forssmann WG
    World J Urol; 1996; 14(6):375-9. PubMed ID: 8986039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ANP and urodilatin: who is who in the kidney.
    Hirsch JR; Meyer M; Forssmann WG
    Eur J Med Res; 2006 Oct; 11(10):447-54. PubMed ID: 17107879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urodilatin, a natriuretic peptide with clinical implications.
    Meyer M; Richter R; Forssmann WG
    Eur J Med Res; 1998 Feb; 3(1-2):103-110. PubMed ID: 9512977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endocrine heart and natriuretic peptides: histochemistry, cell biology, and functional aspects of the renal urodilatin system.
    Forssmann WG; Richter R; Meyer M
    Histochem Cell Biol; 1998 Oct; 110(4):335-57. PubMed ID: 9792413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal natriuretic peptide (urodilatin?) and atriopeptin: evolving concepts.
    Goetz KL
    Am J Physiol; 1991 Dec; 261(6 Pt 2):F921-32. PubMed ID: 1836308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urodilatin is involved in sodium homeostasis and exerts sodium-state-dependent natriuretic and diuretic effects.
    Meyer M; Richter R; Brunkhorst R; Wrenger E; Schulz-Knappe P; Kist A; Mentz P; Brabant EG; Koch KM; Rechkemmer G; Forssmann WG
    Am J Physiol; 1996 Sep; 271(3 Pt 2):F489-97. PubMed ID: 8853410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urodilatin binds to and activates renal receptors for atrial natriuretic peptide.
    Valentin JP; Sechi LA; Qui C; Schambelan M; Humphreys MH
    Hypertension; 1993 Apr; 21(4):432-8. PubMed ID: 8384600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal and systemic effects of urodilatin in rats with high-output heart failure.
    Abassi ZA; Powell JR; Golomb E; Keiser HR
    Am J Physiol; 1992 Apr; 262(4 Pt 2):F615-21. PubMed ID: 1533100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal effects of urodilatin and atrial natriuretic peptide in volume expanded conscious dogs.
    Bestle MH; Bie P
    Acta Physiol Scand; 1993 Sep; 149(1):77-83. PubMed ID: 8237425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ularitide for the treatment of acute decompensated heart failure: from preclinical to clinical studies.
    Anker SD; Ponikowski P; Mitrovic V; Peacock WF; Filippatos G
    Eur Heart J; 2015 Mar; 36(12):715-23. PubMed ID: 25670819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The renal natriuretic peptide urodilatin is present in human kidney.
    Herten M; Lenz W; Gerzer R; Drummer C
    Nephrol Dial Transplant; 1998 Oct; 13(10):2529-35. PubMed ID: 9794555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that urodilatin, rather than ANP, regulates renal sodium excretion.
    Goetz K; Drummer C; Zhu JL; Leadley R; Fiedler F; Gerzer R
    J Am Soc Nephrol; 1990 Dec; 1(6):867-74. PubMed ID: 1966524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urodilatin (ularitide, INN): a renal natriuretic peptide. Molecular biology and clinical importance.
    Forssmann WG
    Nephron; 1995; 69(3):211-22. PubMed ID: 7753251
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of renal actions of urodilatin and atrial natriuretic peptide.
    Hildebrandt DA; Mizelle HL; Brands MW; Hall JE
    Am J Physiol; 1992 Mar; 262(3 Pt 2):R395-9. PubMed ID: 1313650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of effect of atrial natriuretic peptide and urodilatin on vasopressin-stimulated cyclic AMP production in microdissected rat inner medullary collecting ducts.
    Burgess WJ; Perrott MN; Balment RJ
    J Mol Endocrinol; 1994 Apr; 12(2):149-54. PubMed ID: 8060479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Urodilatin--renal representative of the natriuretic family of peptides].
    Wiecek A; Chudek J; Karkoszka H
    Pol Arch Med Wewn; 1994 Feb; 91(2):132-40. PubMed ID: 8008618
    [No Abstract]   [Full Text] [Related]  

  • 18. Basic aspects of vasorelaxant and bronchodilating peptides in clinical use: urodilatin (INN: Ularitide), VIP, and PACAP.
    Meyer M; Flüge T; Kruhøffer M; Forssmann WG
    Ann N Y Acad Sci; 1996 Dec; 805():443-61; discussion 461-3. PubMed ID: 8993423
    [No Abstract]   [Full Text] [Related]  

  • 19. [Urodilatin. Use of a new peptide in intensive care].
    Meyer M; Schulz-Knappe P; Kuse ER; Hummel M; Hetzer R; Pichlmayr R; Forssmann WG
    Anaesthesist; 1995 Feb; 44(2):81-91. PubMed ID: 7702187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urodilatin: a better natriuretic peptide?
    Vesely DL
    Curr Heart Fail Rep; 2007 Sep; 4(3):147-52. PubMed ID: 17883990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.